Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients.
Tan Q, Gao R, Zhang X, Yang J, Xing P, Yang S, Wang D, Wang G, Wang S, Yao J, Zhang Z, Tang L, Yu X, Han X, Shi Y.
Tan Q, et al. Among authors: wang g, wang d, wang s.
Cancer Immunol Immunother. 2024 Feb 13;73(3):47. doi: 10.1007/s00262-024-03631-7.
Cancer Immunol Immunother. 2024.
PMID: 38349411
Free PMC article.